Jazz Pharmaceuticals (United States)
In research, Jazz Pharmaceuticals (United States) stands highest in Medicine (#14,759 of 17,978 worldwide) and Health Sciences (#16,913 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Cognitive Neuroscience and Neuroscience — Cognitive Neuroscience is 29.6× its share of world research.
- World rank, 2022–2025
- #21,680 of 28,054 · #26,065 all time
- Rank in United States
- #3,203 of 4,192
- Research works
- 276 ▲ 120% vs 2013–17
- Citations
- 4.3k 15.5 per fractional work
- Top-10% rate
- 9.7% record average 16.5%
- Open access
- 47% world 28%
What is Jazz Pharmaceuticals (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #14,759 of 17,978 | 12.7% | 132 | |
| Health SciencesDomain | #16,913 of 20,462 | 13.5% | 138 |
Each strip is that field’s whole ranked pool, with the notch where Jazz Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Jazz Pharmaceuticals (United States) specialise in?
Where its research is concentrated relative to its size: Cognitive Neuroscience takes 29.6× the share of its output that it takes of world research.
- Cognitive NeuroscienceSubfield · 22.6 works30×
- NeuroscienceField · 25.1 works15×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 14.8×. Every wedge is a field page.
- Neuroscience 14.8×
- Psychology 4.0×
- Nursing 3.8×
- Medicine 2.3×
- Veterinary 1.8×
- Biochemistry, Genetics and Molecular Biology 1.6×
- Decision Sciences 1.0×
- Chemistry 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Economics, Econometrics and Finance 0.6×
- Health Professions 0.4×
- Business, Management and Accounting 0.3×
- Arts and Humanities 0.2×
- Immunology and Microbiology 0.2×
- Physics and Astronomy 0.2×
- Mathematics 0.2×
- Materials Science 0.1×
- Social Sciences 0.1×
- Computer Science 0.1×
- Engineering 0.0×
- Environmental Science 0.0×
- Agricultural and Biological Sciences 0.0×
Who are the top researchers at Jazz Pharmaceuticals (United States)?
Ranked on the composite score, Jed Black, Kathleen F. Villa and Douglas S. Fuller lead among researchers whose main affiliation is Jazz Pharmaceuticals (United States).
- 1 Jed Black United States · #115,035 worldwide 177 citations · 28 works
- 2 Kathleen F. Villa United States · #503,451 worldwide 50 citations · 18 works
- 3 Douglas S. Fuller United States · #567,282 worldwide 67 citations · 17 works
- 4 Wayne Macfadden United States · #780,796 worldwide 44 citations · 18 works
- 5 Ben Taylor United States · #1,169,148 worldwide 31 citations · 15 works
- 6 Diane Ito United States · #1,397,752 worldwide 9 citations · 20 works
Which keywords describe research at Jazz Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Circadian Rhythms, Memory, Sleep, Epidemiology, Meta-Analysis, Insomnia, Sleep Duration and Prognostic Factors.
- Cognitive Impairment
- AML
- Minimal Residual Disease
- Sleep-Disordered Breathing
- Metabolism
- Mortality
- Cancer Therapy
- Endocannabinoid System
- Neuroprotection
- Small-Cell Lung Cancer
- Hematopoietic Stem Cells
- Metastasis
- Inflammation
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Prognostic Factors
- Insomnia
- Epidemiology
- Memory
- Circadian Rhythms
- Sleep
- Meta-Analysis
- Sleep Duration
- Neurological Disorders
- Clinical Trials
- Cardiovascular Disease
- Epilepsy
- Hypertension
- Biomarkers
- Genomic Profiles
- Metabolic Disorders
- Cannabinoid Receptors
- Insulin Resistance
- Genetic Mutations
- Diagnostic Criteria
- Obstructive Sleep Apnea
- Antiepileptic Drugs
- Neurobiology
- Acute Myeloid Leukemia
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Circadian Rhythms31▲ 287×2 topics
- Memory20▲ 78×1 topic
- Sleep20▲ 488×1 topic
- Epidemiology17▲ 4.1×14 topics
- Meta-Analysis11▲ 18×2 topics
- Insomnia11▲ 155×1 topic
- Sleep Duration11▲ 165×1 topic
- Prognostic Factors9▲ 20×6 topics
- Neurological Disorders8▲ 13×13 topics
- Chemotherapy8▲ 10×9 topics
- Clinical Trials7▲ 9.7×9 topics
- Targeted Therapy5▲ 23×4 topics
- Cardiovascular Disease5▲ 4.3×9 topics
- Immunotherapy5▲ 6.6×8 topics
- Epilepsy5▲ 43×4 topics
- Inflammation5▲ 2.1×17 topics
- Hypertension4▲ 15×3 topics
- Metastasis4▲ 11×2 topics
- Biomarkers4▲ 5.4×3 topics
- Hematopoietic Stem Cells4▲ 43×3 topics
- Genomic Profiles4▲ 86×1 topic
- Small-Cell Lung Cancer4▲ 86×1 topic
- Metabolic Disorders4▲ 30×3 topics
- Neuroprotection4▲ 9.6×2 topics
- Cannabinoid Receptors3▲ 97×1 topic
- Endocannabinoid System3▲ 97×1 topic
- Insulin Resistance3▲ 7.2×5 topics
- Cancer Therapy3▲ 5.4×9 topics
- Genetic Mutations3▲ 7.0×10 topics
- Mortality3▲ 5.1×5 topics
- Diagnostic Criteria3▲ 13×4 topics
- Metabolism3▲ 5.2×7 topics
- Obstructive Sleep Apnea3▲ 59×1 topic
- Sleep-Disordered Breathing3▲ 59×1 topic
- Antiepileptic Drugs2▲ 29×2 topics
- Minimal Residual Disease2▲ 31×2 topics
- Neurobiology2▲ 8.3×4 topics
- AML2▲ 42×1 topic
- Acute Myeloid Leukemia2▲ 42×1 topic
- Cognitive Impairment2▲ 7.9×5 topics
Which research topics does Jazz Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Sleep and Wakefulness Research, Sleep and related disorders, Lung Cancer Research Studies and Cannabis and Cannabinoid Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Sleep and Wakefulness Research Cognitive Neuroscience 20 works
- 2 Sleep and related disorders Experimental and Cognitive Psychology 11 works
- 3 Lung Cancer Research Studies Oncology 4 works
- 4 Cannabis and Cannabinoid Research Pharmacology 3 works
- 5 Obstructive Sleep Apnea Research Physiology 3 works
- 6 Acute Myeloid Leukemia Research Hematology 2 works
- 7 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 2 works
- 8 Epilepsy research and treatment Psychiatry and Mental health 2 works
- 9 EEG and Brain-Computer Interfaces Cognitive Neuroscience 2 works
- 10 Hematopoietic Stem Cell Transplantation Hematology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Jazz Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 120% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Palo Alto
- Hewlett-Packard (United States)
- Electric Power Research Institute
- Palo Alto Research Center
- Palo Alto University
- VA Palo Alto Health Care System
- Varian Medical Systems (United States)
- Science Exchange (United States)
- Lucile Packard Children's Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.